Literature DB >> 12089647

[European Community Respiratory Health Survey in Adults (ECRHS)].

J Heinrich1, K Richter, C Frye, I Meyer, G Wölke, M Wjst, D Nowak, H Magnussen, H E Wichmann.   

Abstract

The European Community Respiratory Health Survey (ECRHS) was the first study to assess the geographical variation in asthma, allergy, and allergic sensitization in adults using the same instruments and definitions. The database of the ECRHS includes information from approximately 140 000 individuals aged 20 - 44 years from 22 countries. The aim of this review is to summarize the results of the ECRHS and to present the specific contribution of the German centers in Hamburg and Erfurt. The prevalence ranged from 2.0 - 11.9 % for asthma, 9.5 - 40.9 % for allergic rhinitis, 4.0 - 32.0 % for wheeze, 3.4 - 27.9 % for bronchial hyperreactivity, and 16.2 - 44.5 % for allergic sensitisation against common aeroallergens. Although the prevalence of these atopic disorders were found to be consistently higher for the Hamburg center compared to the Erfurt center, strong regional differences in the prevalences were also found within several other European countries. Overall Europe, the lowest prevalences were seen in the Eastern and Middle European countries with the center Erfurt, followed by the Mediterranean region. The highest prevalences were reported for all English speaking centers. Strong geographic variation was reported for medication for asthma. Asthma seems to be undertreated in several countries. Environmental exposures and in particular indoor factors, and exposures at the workplace are playing a major role for asthma in adulthood. Furthermore, protective effects on atopy were found for exposures to pets (dogs) and a large number of siblings in early childhood. In conclusion, the ECRHS has shown that the prevalence of asthma varies widely. The fact that the geographical pattern is consistent with the distribution of atopy and bronchial responsiveness supports the conclusion that the geographical variations in the prevalence of asthma are true and likely due to environmental factors.

Entities:  

Mesh:

Year:  2002        PMID: 12089647     DOI: 10.1055/s-2002-30699

Source DB:  PubMed          Journal:  Pneumologie        ISSN: 0934-8387


  8 in total

Review 1.  [Endoscopic asthma therapy. Sense and nonsense].

Authors:  F J F Herth
Journal:  Internist (Berl)       Date:  2008-11       Impact factor: 0.743

2.  Epidemiology in Germany-general development and personal experience.

Authors:  Heinz-Erich Wichmann
Journal:  Eur J Epidemiol       Date:  2017-08-16       Impact factor: 8.082

Review 3.  How Do Pollen Allergens Sensitize?

Authors:  Svetlana V Guryanova; Ekaterina I Finkina; Daria N Melnikova; Ivan V Bogdanov; Barbara Bohle; Tatiana V Ovchinnikova
Journal:  Front Mol Biosci       Date:  2022-06-16

4.  Healthcare utilisation and costs associated with adding montelukast to current therapy in patients with mild to moderate asthma and co-morbid allergic rhinitis: PRAACTICAL study.

Authors:  Roberto Dal Negro; Peter Piskorz; Roberto Vives; Magda Guilera; Vasilisa Sazonov Kocevar; Xavier Badia
Journal:  Pharmacoeconomics       Date:  2007       Impact factor: 4.981

5.  Perceptions and Management of Allergic Rhinitis Among Ecuadorian Otorhinolaryngologists: A Survey-Based Study.

Authors:  Miguel Felix; Carlos Vera Paz; Valeria L Mata; Emanuel Vanegas; Désirée Larenas-Linnemann; Nelson A Rosario; Jose Letort; Ivan Cherrez-Ojeda
Journal:  J Multidiscip Healthc       Date:  2020-12-17

6.  Lipid Cubic Systems for Sustained and Controlled Delivery of Antihistamine Drugs.

Authors:  Michele Dully; Miriama Ceresnakova; David Murray; Tewfik Soulimane; Sarah P Hudson
Journal:  Mol Pharm       Date:  2021-09-21       Impact factor: 4.939

7.  Prevalence and severity of differing dimensions of breathlessness among elderly males in the population.

Authors:  Max Olsson; David C Currow; Miriam J Johnson; Jacob Sandberg; Gunnar Engström; Magnus Ekström
Journal:  ERJ Open Res       Date:  2021-02-07

8.  Current status of allergy prevalence in Germany: Position paper of the Environmental Medicine Commission of the Robert Koch Institute.

Authors:  Karl-Christian Bergmann; Joachim Heinrich; Hildegard Niemann
Journal:  Allergo J Int       Date:  2016-02-11
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.